Biosyntech Competitors

Analyzing Biosyntech competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Biosyntech to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.

Biosyntech vs Grapefruit USA Correlation

Significant diversification

The correlation between Biosyntech and GPFT is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Biosyntech and GPFT in the same portfolio, assuming nothing else is changed.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biosyntech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details
Naive
Forecast
LowNextHigh
0.0000030.0000030.000003
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.0600
Details

Biosyntech Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Biosyntech and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Biosyntech and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Biosyntech does not affect the price movement of the other competitor.

High positive correlations

EMDFNBIO
CHNXFRGRX
AOXGCHNXF
GPFTNBIO
AOXGRGRX
NBIOHMGN
  

High negative correlations

NBIORGRX
EMDFRGRX
CHNXFNBIO
CHNXFEMDF
GPFTCHNXF
AOXGNBIO

Risk-Adjusted Indicators

There is a big difference between Biosyntech Pink Sheet performing well and Biosyntech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biosyntech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
HMGN  3.01  0.73  0.00  1.47  0.00 
 0.00 
 100.00 
RGRX  1.49  0.74  0.00  3.17  0.00 
 0.00 
 50.00 
QRON  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
NBIO  21.31  4.12  0.06 (0.32) 22.73 
 100.00 
 212.50 
EMDF  3.15 (0.39) 0.00 (0.19) 0.00 
 6.06 
 72.21 
SFLM  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
DRWN  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CHNXF  17.64  9.23  0.00 (1.07) 0.00 
 0.00 
 590.91 
AOXG  12.07  3.49  0.12 (0.77) 10.80 
 33.33 
 127.17 
GPFT  9.46  1.23  0.06 (2.37) 9.98 
 20.00 
 66.67 

Biosyntech Competitive Analysis

The better you understand Biosyntech competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Biosyntech's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Biosyntech's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
HMGN RGRX QRON NBIO EMDF SFLM CHNXF AOXG GPFT
 0.00 
 0.0002 
Hemagen
 0.00 
 0.0003 
Regenerx
 0.00 
 0.01 
Qrons
 0.00 
 0.0003 
Nascent
 0.00 
 0 
EMDF
 0.00 
 0.0001 
SFLMaven
 0.00 
 0.01 
ChitogenX
 1.35 
 0.01 
Aoxing
 20.00 
 0.0006 
Grapefruit
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Z Score
Return On Asset
Book Value Per Share
Number Of Shares Shorted
Current Liabilities
Total Asset
Target Price
Short Ratio
Debt To Equity
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Biosyntech Competition Performance Charts

Five steps to successful analysis of Biosyntech Competition

Biosyntech's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Biosyntech in relation to its competition. Biosyntech's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Biosyntech in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Biosyntech's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Biosyntech, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Biosyntech position

In addition to having Biosyntech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Gold and Gold Mining Thematic Idea Now

Gold and Gold Mining
Gold and Gold Mining Theme
Large and mid-size companies, ETFs and funds that are either investing, exploring or producing, gold or indirectly involved in trading or making gold products. The Gold and Gold Mining theme has 100 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gold and Gold Mining Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Consideration for investing in Biosyntech Pink Sheet

If you are still planning to invest in Biosyntech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biosyntech's history and understand the potential risks before investing.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
CEOs Directory
Screen CEOs from public companies around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments